Evidence map›Paper›PMID 25360552›Full record

ArticlePloS one2014

Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.

Ratish Gambhira, Brandon F Keele, John B Schell, Meredith J Hunter, Jason P Dufour, David C Montefiori, Haili Tang, John K Rose, Nina Rose, Preston A Marx

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Self-Amplifying RNA Viruses as RNA Vaccines.International journal of molecular sciences · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ratish GambhiraDivision of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Brandon F KeeleAIDS and Cancer Virus Program, SAIC-Frederick Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
John B SchellDepartment of Pathology, Yale University, New Haven, Connecticut, United States of America.
Meredith J HunterDivision of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Jason P DufourDivision of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
David C MontefioriDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Haili TangDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
John K RoseDepartment of Pathology, Yale University, New Haven, Connecticut, United States of America.
Nina RoseDepartment of Pathology, Yale University, New Haven, Connecticut, United States of America.
Preston A MarxDivision of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Tulane University · USYale University · USDuke Medical Center · USFrederick National Laboratory for Cancer Research · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
IMMUNE RESPONSES TO VSV/HIV/SIV HYBRIDS IN MACAQUESR01AI045510 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN K. · 1999 to 2010
$6.4M
Research Training in Experimental Medicine and PathologyT32OD011124 · OD · TULANE UNIVERSITY OF LOUISIANA · PI BLAIR, ROBERT, RAPPAPORT, JAY · 2012 to 2019
$2.7M
Research Training in Experimental Medicine and PathologyT32RR021309 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI LACKNER, ANDREW A · 2005 to 2011
$2.3M
Immune Responses to VSV/HIV/SIV Hybrids in MacaquesR56AI045510 · NIAID · YALE UNIVERSITY · PI ROSE, JOHN K. · 2008 to 2011
$938k
Research Training in Veterinary & Comparative PathologyT32OD011064 · OD · HARVARD MEDICAL SCHOOL · PI SPEALMAN, ROGER D · 2012 to 2014
$694k
CCR NIH HHS HHSN261200800001CNCATS NIH HHS UL1 TR000142NCI NIH HHS HHSN261200800001ENCRR NIH HHS P51 RR000164NCRR NIH HHS P51 RR00164NCRR NIH HHS T32 RR021309NIAID NIH HHS AI45510NIAID NIH HHS R01 AI045510NIAID NIH HHS R56 AI045510NIH HHS P51 OD011104NIH HHS T32 OD011064NIH HHS T32 OD011124
6 · The paper itself

Abstract

Identification of transmitted/founder simian immunodeficiency virus (SIV) envelope sequences responsible for infection may prove critical for understanding HIV/SIV mucosal transmission. We used single genome amplification and phylogenetic analyses to characterize transmitted/founder SIVs both in the inoculum and in immunized-infected rhesus monkeys. Single genome amplification of the SIVsmE660 inoculum revealed a maximum diversity of 1.4%. We also noted that the consensus sequence of the challenge stock differed from the vaccine construct in 10 amino acids including 3 changes in the V4 loop. Viral env was prepared from rhesus plasma in 3 groups of 6 immunized with vesicular stomatitis virus (VSV) vectors and boosted with Semliki forest virus (SFV) replicons expressing (a) SIVsmE660 gag-env (b) SIVsmE660 gag-env plus rhesus GM-CSF and (c) control influenza hemagglutinin protein. Macaques were immunized twice with VSV-vectors and once with SFV vector and challenged intrarectally with 4000 TCID50. Single genome amplification characterized the infections of 2 unprotected animals in the gag-env immunized group, both of which had reduced acute plasma viral loads that ended as transient infections indicating partial immune control. Four of 6 rhesus were infected in the gag-env + GM-CSF group which demonstrated that GM-CSF abrogated protection. All 6 animals from the control group were infected having high plasma viral loads. We obtained 246 full-length envelope sequences from SIVsmE660 infected macaques at the peak of infection and determined the number of transmitted/founder variants per animal. Our analysis found that 2 of 2 gag-env vaccinated but infected macaques exhibited single but distinct virus envelope lineages whereas rhesus vaccinated with gag-env-GM-CSF or HA control exhibited both single and multiple env lineages. Because there were only 2 infected animals in the gag-env vaccinated rhesus compared to 10 infected rhesus in the other 2 groups, the significance of finding single env variants in the gag-env vaccinated group could not be established.

Indexed as

PhylogenyAnimalsGene Products, envGene Products, gagGenetic VectorsGranulocyte-Macrophage Colony-Stimulating FactorImmunizationMacaca mulattaMolecular Sequence DataSAIDS VaccinesSemliki forest virusSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusVesicular StomatitisViral Envelope ProteinsViral LoadGene Products, envGene Products, gagGranulocyte-Macrophage Colony-Stimulating FactorSAIDS VaccinesViral Envelope Proteins

Identifiers

PMID25360552
PMCPMC4215841
OpenAlexW2067409516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.